Chemobrain The Flip Side Of Surviving Cancer
Main Category: Cancer / OncologyArticle Date: 18 Sep 2009 - 2:00 PDT
| Patient / Public: | ![]() |
5 (3 votes) |
| Healthcare Prof: | ![]() |
5 (2 votes) |
| Article Opinions: | 2 posts |
Study shows deterioration in brain function following breast cancer therapy has negative effects on quality of life
One of the most problematic side effects of cancer treatment, chemobrain a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning. As a result, they have to adopt a range of coping strategies to manage their restricted social and professional lives.
Breast cancer survivors tell their story in a descriptive study1 of the effects that cognitive impairment has on women's work, social networks and dealings with the health care profession. Dr. Saskia Subramanian from the UCLA Center for Culture and Health in the US and her colleagues have just published their work online in Springer's Journal of Cancer Survivorship.
An increasing number of women survive breast cancer, yet survival comes at a price. Mild cognitive impairment following chemotherapy, known as "chemobrain" or "chemofog" is one of the most commonly reported post-treatment symptoms by breast cancer survivors. Dr. Subramanian and colleagues' work shows that this deterioration in brain function has devastating effects on breast cancer survivors' quality of life.
Through a combination of focus groups and in-depth interviews among 74 women who had completed their course of cancer treatment at least a year earlier, the researchers gathered data on patients' medical background, treatment experience, post-treatment symptoms, reactions from medical staff and from family and friends, self-management, strength of social networks and their perceptions of themselves.
The women described a variety of cognitive changes which they found both frustrating and upsetting. Some were less able to retain material or to digest new information and recognized that they were not functioning as they once did. Others faced reduced independence, becoming limited in their ability to manage certain responsibilities or get around. These changes made women feel scared, dependent and emotionally drained. For some, coping meant having to cut back on work and social activities. Others had more or less accepted the limitations put on their lives and resigned themselves to a diminished cognitive capacity.
The majority of women complained about the lack of acknowledgement from the medical community when they mentioned their chemobrain symptoms. Many women wished they had received some warning and only a few got answers from their physicians. Some women felt that chemobrain confused their families and friends, and young children in particular.
Chemobrain also affected women's performance at work. Because they were less able to focus, duties became more difficult and often took longer. This affected their efficiency and reduced their chances of promotion or assignment to projects.
The authors conclude: "These data underscore the very serious ways in which chemobrain can affect the life experiences of cancer survivors - emotionally, psychologically and economically. A clear understanding of the cognitive impairments experienced by survivors will aid researchers in developing targeted therapies and interventions aimed at improving or mitigating these post-treatment side effects."
Source: Springer Science+Business Media
Visit our cancer / oncology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/164375.php>
APA
http://www.medicalnewstoday.com/releases/164375.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (2)
Resurgence Of Chemobrain Research
posted by Gregory D. Pawelski on 22 Sep 2009 at 8:34 pmIt's good to see the resurgence of chemotherapy side effect research. They need to help raise consciousness about the subject of Chemo Brain. All those cancer patients ignored or just plain ridiculed all these years.
Chemo Brain is part of the language now and just to have it acknowledged makes a difference. The choice of researchers to integrate promising insights and methods remains an essential component of new paradigms of cancer treatment.
There are many reasons as to why chemobrain may occur. One is that some types of chemotherapy can cross the blood/brain barrier. Another is that the cognitive problems are created by free radicals, the toxic elements that many types of chemotherapy produce. And yet another is that some people have a genetic background that makes them more susceptible to the effects of chemotherapy. Most likely it is not just one factor but many factors that combine to set the stage for chemobrain to occur.
According to studies by Dartmouth-Hitchcock Medical Center, even standard-dose chemotherapy can negatively impact the cognitive functioning of cancer survivors up to 10 years after treatment. Reports of depression, anxiety, and fatigue, all of which can affect cognitive functioning, suggests that the differences in performance on cognitive tests were due to the chemotherapy itself, not to greater levels of depression, anxiety, and fatigue in patients who received chemotherapy.
Chemo Brain
posted by Nancy Mader on 1 Oct 2009 at 2:17 pmI am reading everything I can find regarding this condition since my 83 year old husband was treated for ITP (idiopathic thrombocytopenia) last May-June, 2009. Prior to this onset he was very healthy with no major illnesses and a very young 83. He was given cicplatin 2 doses, with no response. This was followed by three or four doses of reduxin which apparently was responsible for his platelet count and red cell count to start to return to a more normal level. In June he was transfered to a rehab facility due to his inability to walk.
He seemed to get better, but the staff and I noticed he was making poor decisions regarding his care. He also was failing to remember simple discussions we would have. This condition seemed to me to be getting worse but he was transfered home.I was unable to care for him since he had trouble walking even with a walker and assistance. He was again admitted to rehab in mid July where his inability to funcion became worse by the day. In his final weeks I had to feed him, he was unable to comunicate and he died two months after the July admission. His death certificate says "aggressive dementia" apparently secondary to the chemo drugs.
Can anyone help me with more insight?
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




